Health & Environmental Research Online (HERO)


Print Feedback Export to File
7047828 
Journal Article 
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes 
Wainstein, J; Katz, L; Engel, SS; Xu, L; Golm, GT; Hussain, S; O'Neill, EA; Kaufman, KD; Goldstein, BJ; , 
2012 
Yes 
Diabetes, Obesity and Metabolism
ISSN: 1462-8902
EISSN: 1463-1326 
14 
5 
409-418 
English 
22059736 
WOS:000302237700003 
To evaluate the efficacy and safety of initial therapy with a fixed-dose combination (FDC) of sitagliptin and metformin compared with pioglitazone in drug-naÏve patients with type 2 diabetes. 
• PFAS Universe
     Data Source
          Web of Science
     Perflunafene